Bone Biologics Corporation
Bone Biologics Corporation (BBLG) Revenue
Annual & quarterly revenue history · segment & region breakdown
BBLG · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBone Biologics Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bone Biologics Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bone Biologics Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bone Biologics Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BBLG revenue · 4 questionsBBLG's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Bone Biologics Corporation SEC filings · GAAP · Bone Biologics Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026